Clinical trial reportAmerican journal of hematologyPublished
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- American journal of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Brain Injuries; Cerebral Infarction; Anemia, Sickle Cell; Hydroxyurea; Antisickling Agents; Feasibility Studies; Pilot Projects; Double-Blind Method; Child, Preschool; Infant; Female
- PubMed ID
- 38953438
- PubMed Central ID
- PMC11502276
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked